Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.634
-0.020 (-3.03%)
At close: Apr 28, 2026, 4:00 PM EDT
0.650
+0.016 (2.49%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Envoy Medical Stock Forecast

COCH's stock price has decreased by -57.15% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Envoy Medical stock have an average target of 6.00, with a low estimate of 2.50 and a high estimate of 9.50. The average target predicts an increase of 846.07% from the current stock price of 0.63.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $2.50 $6.00 $9.50 $9.50
Change +294.20% +846.07% +1398.0% +1398.0%

Analyst Ratings

The average analyst rating for Envoy Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 222222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$2.5
Strong Buy Initiates $2.5 +294.20% Mar 31, 2026
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$9.25$9.5
Strong Buy Maintains $9.25$9.5 +1,397.95% May 27, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$9$9.25
Strong Buy Maintains $9$9.25 +1,358.53% Apr 21, 2025
Ascendiant Capital
Ascendiant Capital
Strong Buy
Maintains
$8.75$9
Strong Buy Maintains $8.75$9 +1,319.11% Dec 6, 2024
Brookline Capital
Brookline Capital
Strong Buy
Initiates
$9
Strong Buy Initiates $9 +1,319.11% Oct 14, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
244.80K
from 241.00K
Increased by 1.58%
Revenue Next Year
n/a
from 244.80K
EPS This Year
-0.31
from -1.23
EPS Next Year
n/a
from -0.31
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
310.00K237.00K316.00K225.00K241.00K244.80K
Revenue Growth
--23.55%33.33%-28.80%7.11%1.58%
EPS
-0.86-1.57-2.54-1.49-1.23-0.31
EPS Growth
------
Forward PE
------
No. Analysts -----3
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2026
High 252,000
Avg 244,800
Low 235,200

Revenue Growth

Revenue Growth 2026
High
4.6%
Avg
1.6%
Low
-2.4%

EPS Forecast

EPS 2026
High -0.32
Avg -0.31
Low -0.29

EPS Growth

EPS Growth 2026
High -
Avg -
Low -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.